Mangoceuticals, Inc. (MGRX) stock
Close on Nov 13, 2026Market cap $3.34MP/E –Yield –
Mangoceuticals statistics
69 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
Enterprise valuationIndustry
- EV / Sales
- 9.87
- 1.67
Share statisticsIndustry
- Shares Change (YoY)
- 208.8%
- 2.40%
- Shares Change (QoQ)
- 6.19%
- 0.33%
- Float
- 9M
- 34M
- Shares Held by Insiders
- 57.8%
- 15.4%
- Shares Held by Institutions
- 5.57%
- 83.6%
Short sellingIndustry
- Short Interest
- 53,343
- –
- Short Interest Change
- -41.7%
- -0.86%
- Short % of Float
- 0.59%
- 6.28%
- Short % of Shares Outstanding
- 0.25%
- 4.21%
- Days to Cover
- 1.00
- 4.41
Stock price statisticsIndustry
- 52-Week High
- $2.28
- –
- 52-Week Low
- $0.15
- –
- 20-Day Moving Average
- $0.23
- –
- 50-Day Moving Average
- $0.34
- –
- 200-Day Moving Average
- $0.39
- –
- Average True Range (14)
- $0.03
- –
- Price Change (1 Week)
- -20.5%
- 0.23%
- Price Change (1 Month)
- -51.7%
- -0.02%
- Price Change (3 Months)
- -70.7%
- 2.13%
- Price Change (6 Months)
- -64.8%
- 17.6%
- Price Change (YTD)
- -79.1%
- 5.22%
- Price Change (1 Year)
- -91.2%
- 3.75%
- Price Change (3 Years)
- -97.6%
- 15.2%
- Average Volume (10 Days)
- 1M
- –
- Average Volume (20 Days)
- 827,494
- –
- Average Volume (90 Days)
- 9M
- –
- Relative Volume
- 0.10
- 0.70
- Relative Strength Index (14)
- 24.8
- 46.0
- Volatility (1 Year)
- 213.6%
- 64.2%
- Beta (5 Years)
- -1.27
- 0.76
MarginsIndustry
- Pretax Margin
- -4791.5%
- 2.12%
- EBITDA Margin
- -3829.0%
- 3.36%
Returns on capitalIndustry
- Return on Equity (ROE)
- -95.1%
- 4.82%
- Return on Assets (ROA)
- -86.3%
- -3.10%
- Return on Invested Capital (ROIC)
- -60.7%
- 4.69%
- Return on Capital Employed (ROCE)
- -94.5%
- 0.40%
Financial positionIndustry
- Current Ratio
- 0.18
- 1.41
- Quick Ratio
- 0.16
- 0.99
GrowthIndustry
- Revenue Growth (YoY)
- -38.9%
- 9.63%
- Revenue Growth (3Y CAGR)
- 270.9%
- 11.3%
EfficiencyIndustry
- Asset Turnover
- 0.02
- 0.81
- WACC
- 7.60%
- 8.40%
Income statement (TTM)Industry
- Pretax Income
- -$15.10M
- -$575.82K
Balance sheetIndustry
- Net Cash (Debt)
- $228.69K
- $203.66K
- Net Cash Per Share
- $0.01
- $0.00
- Equity (Book Value)
- $12.53M
- $235.60M
- Book Value Per Share
- $0.58
- $3.91
- Tangible Book Value
- -$1.12M
- $1.59M
- Working Capital
- -$1.15M
- $30.06M
Cash flow (TTM)Industry
Dividends and yieldsIndustry
- Earnings Yield
- -451.8%
- 0.19%
Scores and fair valueIndustry
- Altman Z-Score
- -6.15
- 2.24
- Piotroski F-Score
- 3
- 5
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | MGRX | S&P 500 | Difference | MGRX per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -58.3% | -3.0% | −55.2 pts | ||
| 3 months | -70.9% | -2.8% | −68.1 pts | ||
| Year to date | -79.1% | +11.5% | −90.5 pts | ||
| 1 year | -87.0% | +13.5% | −100.4 pts | ||
| 3 years | -97.6% | +77.7% | −175.3 pts | -71.3% | +21.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
0M MGRX shares were sold short on Oct 30, 2026, down 41.7% from the previous report, or 0.59% of the shares available to trade. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 24.6% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 53,343 | -41.7% | 369,429 | 1.0 |
| Oct 15, 2026 | 91,564 | -79.1% | 739,664 | 1.0 |
| Sep 30, 2026 | 438,786 | -15.8% | 655,308 | 1.0 |
| Sep 15, 2026 | 521,424 | -17.6% | 298,483 | 1.8 |
| Aug 31, 2026 | 632,502 | -65.1% | 861,529 | 1.0 |
| Aug 14, 2026 | 1,812,630 | -3.7% | 19,098,759 | 1.0 |
| Jul 31, 2026 | 1,882,096 | +805.4% | 49,406,730 | 1.0 |
| Jul 15, 2026 | 207,868 | -46.1% | 627,822 | 1.0 |
| Jun 30, 2026 | 385,972 | +43.6% | 4,330,392 | 1.0 |
| Jun 15, 2026 | 268,818 | +16.3% | 325,680 | 1.0 |
| May 29, 2026 | 231,103 | -39.3% | 494,880 | 1.0 |
| May 15, 2026 | 380,693 | -15.7% | 1,113,840 | 1.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?